Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study
随机、安慰剂对照的 I 期临床试验，评估连续或周期性使用 90 天替诺福韦加左炔诺孕酮阴道环对女性的安全性、药代动力学、药效学和可接受性：CONRAD 138 研究
期刊:PLoS One
影响因子:2.9
doi:10.1371/journal.pone.0275794
Andrea R Thurman, Vivian Brache, Leila Cochon, Louise A Ouattara, Neelima Chandra, Terry Jacot, Nazita Yousefieh, Meredith R Clark, Melissa Peet, Homaira Hanif, Jill L Schwartz, Susan Ju, Mark A Marzinke, David W Erikson, Urvi Parikh, Betsy C Herold, Raina N Fichorova, Elizabeth Tolley, Gustavo F Do
